Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

3.99
-1.3500-25.28%
Volume:158.94K
Turnover:659.29K
Market Cap:2.19M
PE:-0.04
High:4.90
Open:4.90
Low:3.74
Close:5.34
52wk High:179.19
52wk Low:3.74
Shares:547.78K
Float Shares:547.42K
Volume Ratio:11.41
T/O Rate:29.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-102.4151
EPS(LYR):-337.9329
ROE:-705.71%
ROA:-127.92%
PB:0.44
PE(LYR):-0.01

Loading ...

Artelo Biosciences announces results from nonclinical study of ART27.13

TIPRANKS
·
3 hours ago

Artelo Says Oral Art27.13 Matches Semaglutide Weight Loss in Obese Mice Study

Reuters
·
3 hours ago

Artelo Biosciences - Art27.13 Shows no Effect on Body Weight or Fat Mass in Lean Mice

THOMSON REUTERS
·
3 hours ago

Artelo Biosciences Announces Art27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity

THOMSON REUTERS
·
3 hours ago

Artelo Biosciences - Art27.13 Monotherapy Reduces Body Weight by 20% in Obese Mice, Matching Semaglutide

THOMSON REUTERS
·
3 hours ago

Artelo Biosciences CEO Presents at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 08

Artelo Biosciences Inc trading halted, news pending

TIPRANKS
·
Aug 29

Artelo Biosciences Announces Reverse Stock Split

THOMSON REUTERS
·
Aug 27

Artelo secures Japan patent allowance for ART27.13 commercial formulation

TIPRANKS
·
Aug 20

Artelo Biosciences Wins Japan Patent Allowance for Art27.13 Commercial Formulation

Reuters
·
Aug 20

Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of Art27.13

THOMSON REUTERS
·
Aug 20

Artelo Biosciences - Art27.13 Patent Estate Issued or Allowed in US, Japan, Europe

THOMSON REUTERS
·
Aug 20

Artelo Biosciences - Receives Uspto Notice of Allowance for Art27.13 Formulation Patent

THOMSON REUTERS
·
Aug 17

Artelo Biosciences - Patent Protection for Art27.13 Expected Through 2041

THOMSON REUTERS
·
Aug 17

Artelo Biosciences Gets USPTO Notice of Allowance for Art27.13 Formulation Patent Application

Reuters
·
Aug 17

Equillium Q2 Post Narrower Net Loss than Expected; Starts R&D Initiatives

Reuters
·
Aug 14

Elicio Therapeutics Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 14

Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises

Reuters
·
Aug 14

CV Sciences Q2 Sales Fall on Regulatory Pressure

Reuters
·
Aug 14

Artelo Biosciences Q2 EPS $(0.89) Up From $(16.83) YoY

Benzinga Earnings
·
Aug 13